PARP Inhibitors: 2023 Updates

  Рет қаралды 802

OCRA

OCRA

Күн бұрын

Пікірлер: 1
@Sophia-zk3tw
@Sophia-zk3tw 4 ай бұрын
I am very sensitive to medication and have had problem with side effects
What’s New with PARP Inhibitors and Ovarian Cancer?
58:44
SHARE Cancer Support
Рет қаралды 896
Learn all about PARP inhibitors with Dr Jon Krell, Consultant Medical Oncologist
58:46
JISOO - ‘꽃(FLOWER)’ M/V
3:05
BLACKPINK
Рет қаралды 137 МЛН
Почему Катар богатый? #shorts
0:45
Послезавтра
Рет қаралды 2 МЛН
PARP Inhibitors in GYN Cancers | 2022 Evolution Conference
21:52
Total Health | Oncology
Рет қаралды 1,1 М.
PARP inhibitors in ovarian cancer: Clinical updates from SGO 2023
59:14
Touch Medical Media
Рет қаралды 2,9 М.
What is HRD (Homologous Recombination Deficiency) and how does it impact ovarian cancer?
45:27
Ovacome - the ovarian cancer charity
Рет қаралды 5 М.
Experimental Therapies for Ovarian Cancer (2023)
57:07
The Role of Targeting DNA Repair with PARP
12:24
Grand Rounds in Urology
Рет қаралды 6 М.
New FDA Approved PARP Inhibitor: Talzenna (Talazoparib) & Xtandi | #markscholzmd #AlexScholz #pcri
14:39
PARP Inhibitors and Ovarian Cancer | Memorial Sloan Kettering
17:16
Memorial Sloan Kettering Cancer Center
Рет қаралды 10 М.
Managing Ovarian Cancer Recurrence (2024)
1:00:57
OCRA
Рет қаралды 98